Tilmann Bochtler
German Cancer Research Center(DE)Heidelberg University(DE)University Hospital Heidelberg(DE)Heidelberg University of Education(DE)National Center for Tumor Diseases(DE)DKFZ-ZMBH Alliance(DE)Heidelberg University(US)
Publications by Year
Research Areas
Cancer Diagnosis and Treatment, Acute Myeloid Leukemia Research, Amyloidosis: Diagnosis, Treatment, Outcomes, Cancer Genomics and Diagnostics, Oral and Maxillofacial Pathology
Most-Cited Works
- → Measurable residual disease-guided treatment with azacitidine to prevent haematological relapse in patients with myelodysplastic syndrome and acute myeloid leukaemia (RELAZA2): an open-label, multicentre, phase 2 trial(2018)346 cited
- → Immunohistochemistry in the classification of systemic forms of amyloidosis: a systematic investigation of 117 patients(2011)246 cited
- → Translocation t(11;14) Is Associated With Adverse Outcome in Patients With Newly Diagnosed AL Amyloidosis When Treated With Bortezomib-Based Regimens(2015)224 cited
- → Cancer of unknown primary: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up(2022)181 cited
- → RUNX1-mutated families show phenotype heterogeneity and a somatic mutation profile unique to germline predisposed AML(2020)151 cited
- → AL amyloidosis patients with low amyloidogenic free light chain levels at first diagnosis have an excellent prognosis